Literature DB >> 1698846

Determinants of in vivo histamine release in cutaneous allergic reactions in humans.

P C Atkins1, C von Allmen, M Valenzano, R Olson, M Shalit, B Zweiman.   

Abstract

To determine host factors influencing the magnitude of mediator release during ongoing cutaneous allergic reactions in humans, we compared, in 22 subjects, the first-hour, second- to fifth-hour, and total (0 to 5 hours) skin chamber histamine release to (1) the in vitro reactivity and sensitivity of basophils to antigen for histamine release and (2) skin test sensitivity and reactivity to antigen, histamine, and codeine. There was no significant correlation between the first-hour and second- to fifth-hour histamine release. With a combination of basophil, antigen, histamine, and codeine skin sensitivity and reactivity, 64% to 75% of the magnitude of the first-hour, second- to fifth-hour, and total (0 to 5 hours) skin chamber histamine release could be accounted for. We conclude that antigen-induced in vivo allergic responses are a complex phenomenon dependent, in part, on antigen sensitivity, basophil and mast cell reactivity, and end organ responsiveness to mediators.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1698846     DOI: 10.1016/s0091-6749(05)80100-9

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  3 in total

1.  Comparison of serum histamine-releasing activity and clinical manifestations in chronic idiopathic urticaria.

Authors:  T Tanus; P C Atkins; B Zweiman
Journal:  Clin Diagn Lab Immunol       Date:  1996-01

2.  The effect of cetirizine and loratadine on codeine-induced histamine release in human skin in vivo assessed by cutaneous microdialysis.

Authors:  M Perzanowska; D Malhotra; S P Skinner; J P Rihoux; A P Bewley; L J Petersen; M K Church
Journal:  Inflamm Res       Date:  1996-09       Impact factor: 4.575

Review 3.  Anesthetic considerations in pediatric mastocytosis: a review.

Authors:  Norma J Klein; Shad Misseldine
Journal:  J Anesth       Date:  2013-02-14       Impact factor: 2.078

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.